July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Aaron Goodman Highlights IL18-Secreting CAR T Therapy for Refractory Lymphoma
May 9, 2025, 12:28

Aaron Goodman Highlights IL18-Secreting CAR T Therapy for Refractory Lymphoma

Aaron Goodman, Hematologist/Oncologist and an Associate Professor of Medicine at the University of California, shared a post on X:

“This is pretty cool and amazing! Anti-CD19 CART that secretes IL18. 3-day manufacturing process! 50% durable CR in patients with refractory lymphoma who had prior anti-CD19 CAR T. Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure | NEJM.”

Title: Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure

Authors: Jakub Svoboda, Daniel J. Landsburg, James Gerson, Sunita D. Nasta, Stefan K. Barta, Elise A. Chong, Michael Cook, Noelle V. Frey, Joanne Shea, Amanda Cervini, Amy Marshall, Megan Four, Megan M. Davis, Julie K. Jadlowsky, Anne Chew, Edward Pequignot, Vanessa Gonzalez, Julia Han Noll, Luca Paruzzo, Juliana Rojas-Levine, Gabriela Plesa, John Scholler, Donald L. Siegel, Bruce L. Levine, David L. Porter, Saba Ghassemi, Marco Ruella, Andrew Rech, Rachel M. Leskowitz, Joseph A. Fraietta, Wei-Ting Hwang, Elizabeth Hexner, Stephen J. Schuster, Carl H. June

Aaron Goodman Highlights IL18-Secreting CAR T Therapy for Refractory Lymphoma

Read the Full Article on NEJM.

More posts featuring Aaron Goodman.